CNOT6L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.319600E-01
Normal-vs-Stage2
3.953600E-02
Normal-vs-Stage3
2.460400E-01
Normal-vs-Stage4
4.014800E-01
Stage1-vs-Stage2
7.491000E-01
Stage1-vs-Stage3
2.354300E-02
Stage1-vs-Stage4
6.918200E-01
Stage2-vs-Stage3
2.411600E-01
Stage2-vs-Stage4
5.710000E-01
Stage3-vs-Stage4
7.432300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.879800E-01
Normal-vs-AfricanAmerican
5.818600E-01
Normal-vs-Asian
2.813200E-01
Caucasian-vs-AfricanAmerican
1.608240E-01
Caucasian-vs-Asian
1.453600E-01
AfricanAmerican-vs-Asian
6.720400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.652800E-01
Normal-vs-Female
8.436000E-02
Male-vs-Female
2.112400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.637400E-01
Normal-vs-Age(41-60Yrs)
1.726650E-01
Normal-vs-Age(61-80Yrs)
3.549400E-01
Normal-vs-Age(81-100Yrs)
3.017800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.858200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.714400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.792600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.264220E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.921100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.450000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.379000E-01
Normal-vs-Daily Drinker
3.261400E-01
Normal-vs-Weekly Drinker
2.904600E-01
Normal-vs-Occasional Drinker
3.843000E-01
Normal-vs-Social Drinker
3.411600E-01
Non Drinker-vs-Daily Drinker
8.649600E-01
Non Drinker-vs-Weekly Drinker
4.748800E-01
Non Drinker-vs-Occasional Drinker
5.546000E-01
Non Drinker-vs-Social Drinker
1.331170E-01
Daily Drinker-vs-Weekly Drinker
4.810200E-01
Daily Drinker-vs-Occasional Drinker
3.964000E-01
Daily Drinker-vs-Social Drinker
1.453760E-01
Weekly Drinker-vs-Occasional Drinker
2.142400E-01
Weekly Drinker-vs-Social Drinker
8.568400E-02
Occasional Drinker-vs-Social Drinker
3.439600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.786840E-01
Normal-vs-Grade 2
9.223600E-02
Normal-vs-Grade 3
7.039600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.663800E-01
Grade 1-vs-Grade 3
1.750000E-01
Grade 1-vs-Grade 4
1.786840E-01
Grade 2-vs-Grade 3
6.133200E-01
Grade 2-vs-Grade 4
9.223600E-02
Grade 3-vs-Grade 4
7.039600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.372500E-02
Normal-vs-NonDiabetic
3.531400E-01
Diabetic-vs-NonDiabetic
5.439200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.057600E-01
Normal-vs-NoPancreatitis
3.753800E-01
Pancreatitis-vs-NoPancreatitis
8.501900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.262220E-01
Normal-vs-N1
3.839800E-01
N0-vs-N1
6.128200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.162200E-01
Normal-vs-TP53-NonMutant
3.549600E-01
TP53-Mutant-vs-TP53-NonMutant
4.553700E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
